Literature DB >> 31563108

Stereotactic 9-gauge vacuum-assisted breast biopsy, how many specimens are needed?

Bianca M den Dekker1, Paul J van Diest2, Stephanie N de Waard3, Helena M Verkooijen4, Ruud M Pijnappel3.   

Abstract

PURPOSE: To determine the minimum number of stereotactic 9-gauge vacuum-assisted biopsy specimens required to establish a final histopathological biopsy diagnosis of mammographically suspicious breast lesions.
METHODS: This prospective single-center observational cohort study included 120 women referred for stereotactic vacuum-assisted biopsy of 129 mammographically suspicious lesions between December 2017 and October 2018. Stereotactic 9-gauge vacuum-assisted biopsy was performed, acquiring twelve specimens per lesion. Calcification retrieval was assessed with individual specimen radiography. Each specimen was histologically analyzed in chronological order and findings were compared with the final histopathological result after assessment of all twelve specimens and with results of surgical excision. Cumulative diagnostic yield per specimen was calculated.
RESULTS: In total, 131 biopsy procedures were performed in 120 women (mean age 59 years). In 95% (95%CI 90%-98%) of the procedures a final histopathological diagnosis was reached after six specimens. After nine specimens the final biopsy diagnosis was established in all 131 cases. In the subgroup of 41 patients with a DCIS or invasive diagnosis at biopsy there were eight procedures (20%) where calcifications were retrieved before the diagnostic specimen was obtained. Underestimation of subsequent resection diagnosis occurred in six out of 30 excised lesions classified as DCIS (20%) and in one out of four excised high-risk lesions.
CONCLUSIONS: With six stereotactic 9-gauge vacuum-assisted biopsy specimens a final histopathological biopsy diagnosis could be established in 95% (95%CI 90%-98%) of the biopsy procedures. Taking nine 9-gauge specimens seems to be optimal. Ending the stereotactic vacuum-assisted breast biopsy procedure as soon as calcifications are retrieved may cause false negative results.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer; Calcifications; Ductal carcinoma in situ; Stereotactic vacuum-assisted breast biopsy

Year:  2019        PMID: 31563108     DOI: 10.1016/j.ejrad.2019.108665

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  3 in total

1.  The emerging role of contrast-enhanced mammography.

Authors:  Andrea Cozzi; Simone Schiaffino; Francesco Sardanelli
Journal:  Quant Imaging Med Surg       Date:  2019-12

2.  Value of stereotactic 11-gauge vacuum-assisted breast biopsy in non-palpable suspicious calcifications: an eight-year single institution experience with 587 patients.

Authors:  Shiping Li; Feilin Qu; Yinlong Yang; Lei Wang; Juping Shen; Zhiming Shao
Journal:  Gland Surg       Date:  2020-10

3.  Vacuum-Assisted Breast Biopsy System: No Innovation Without Evaluation.

Authors:  Sherif Monib; Soumitra Mukerji; Sonia Narula
Journal:  Cureus       Date:  2021-01-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.